[1]
N. . Akhtar, “Lipid-Based Nano-Formulation Development to Enhance Oral Bioavailability of Weakly Aqueous-Soluble Drug for Obesity and Hypertension”, J. Adv. Zool., vol. 44, no. S5, pp. 1777–1784, Nov. 2023.